The internal promotion at Merck Group's corporate venturing subsidiary followed the departure in May of Jasper Bos.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.

Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.

New Hope Group was among the participants in the dental clinic franchise owner's series B round, which lifted its overall funding past $200m.

The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.

Kaiser Permanente co-led the medical data software provider's latest round, pushing its total funding past the $170m mark.

WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.

Johnson & Johnson, Novartis and Takeda returned to back the cancer and inflammatory drug developer and were joined by investors including AbbVie, Alphabet and Bristol Myers Squibb.

Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.